Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: preliminary results-Reference-Cited by-同舟云学术

Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: preliminary results

Published:2011-10-24 Issue:3 Volume:53 Page:499-502
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Anderlini Paolo,Saliba Rima M.,Ledesma Celina,Chancoco Christina,Alousi Amin M.,Shpall Elizabeth J.,Popat Uday R.,Hosing Chitra M.,Khouri Issa F.,Nieto Yago,Ciurea Stefan,Younes Anas,Fanale Michelle A.,Acholonu Sandra,Valverde Rosamar,Champlin Richard E.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2011.615427

Reference15 articles.

1. Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcome

2. Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation

3. Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience

4. Current role of gemcitabine in the treatment of Hodgkin lymphoma

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preparative Regimens Used in Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapies;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

2. High-Dose Chemotherapy Regimens;Hematopoietic Cell Transplantation for Malignant Conditions;2019

3. Allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma: a systematic review and meta-analysis;Bone Marrow Transplantation;2016-01-04

4. The Emerging Role of Gemcitabine in Conditioning Regimens for Hematopoietic Stem Cell Transplantation;Biology of Blood and Marrow Transplantation;2014-09

5. Relapsed/Refractory Hodgkin Lymphoma;Hematology/Oncology Clinics of North America;2014-02